Intelligence Foundation
Built on verified data — not opinion.
The advisory edge starts here. Every term we anchor, every counterparty we propose, every valuation we sanity-check sits on the same proprietary intelligence foundation — refreshed daily, sourced from primary filings, and refined through every mandate.
Deal Volume by Therapeutic Area
Proprietary dataset · 2017–2026 · n = 2,500+
Platform Ecosystem
Four products. One intelligence layer.
Each platform serves standalone revenue and a conversion funnel into advisory mandates.
Solidus
LiveDeal benchmarking with paid reports and Pro subscriptions. The global on-ramp for operating companies.
Terrain
Coming SoonMarket intelligence for BD teams and investors. Individual, team, and enterprise access.
Investor Intelligence
In DevelopmentSourcing, fund-level benchmarking, LP-grade reporting, portfolio attribution.
IP Map
In DevelopmentPatent intelligence and IP-driven valuation augmentation.
Four platforms. One intelligence layer — powering every advisory mandate with live, verified data.
Strategic Shape Diagnostic
True Platforms receive 2.3x the median upfront.
Most founders don’t know their shape — and the misclassification costs real money.
Every life sciences company preparing for a transaction has a strategic shape. The Shape Diagnostic classifies yours into one of seven archetypes using a scoring engine calibrated against 2,500+ verified transactions — then surfaces the contradictions between your stated identity and what the market evidence actually shows.
Your shape determines which deal structures apply — licensing in or out, M&A on either side, strategic partnerships — which counterparties engage, and what economics to expect. Getting it wrong means running the wrong process with the wrong partners at the wrong valuation.
$49
Full report
Seven minutes. Free classification.
Contradictions, comparable transactions, counterparty map, and a ready-to-use company description paragraph.
Sample Classification
Asset-Led, Platform Aspiration
Confidence: Moderate · 14 points from TP
Contradiction
Capital plan is structured for a single asset, but company describes itself as a platform.
Contradiction
No counterparty has paid to validate the platform beyond the lead program.
Counterfactual
If classified as TP, comparable companies received $310M vs $134Mmedian upfront — a 2.3x difference.
7 Archetypes
Bring us your transaction.
We’ll meet you at peer level — anywhere in the world.